Antiretroviral therapy coverage for PMTCT in Gabon

Gabon: Antiretroviral therapy coverage for PMTCT was 72.0% in 2024. ◆ Volatile

Latest (2024)
72.0%
Change on year
up 14.3%
World rank
49th
of 84 countries
All-time high
83.0%
in 2020
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Gabon, 2000–2024

0204060802000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 1 % of pregnant women living with HIV2004: 3 % of pregnant women living with HIV2005: 3 % of pregnant women living with HIV2006: 4 % of pregnant women living with HIV2007: 15 % of pregnant women living with HIV2008: 21 % of pregnant women living with HIV2009: 19 % of pregnant women living with HIV2010: 20 % of pregnant women living with HIV2011: 26 % of pregnant women living with HIV2012: 34 % of pregnant women living with HIV2013: 43 % of pregnant women living with HIV2014: 44 % of pregnant women living with HIV2015: 53 % of pregnant women living with HIV2016: 66 % of pregnant women living with HIV2017: 61 % of pregnant women living with HIV2018: 65 % of pregnant women living with HIV2019: 68 % of pregnant women living with HIV2020: 83 % of pregnant women living with HIV2021: 65 % of pregnant women living with HIV2022: 70 % of pregnant women living with HIV2023: 63 % of pregnant women living with HIV2024: 72 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Gabon recorded 72.0% for antiretroviral therapy coverage for pmtct in 2024.

That represents a change of up 14.3% on the previous year and up 63.6% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Gabon peaked at 83.0% in 2020 and was at its lowest, 0.0%, in 2000.

That places Gabon 49th out of 84 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Gabon, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Gabon, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 1.0%
2004 3.0% +200.0%
2005 3.0% +0.0%
2006 4.0% +33.3%
2007 15.0% +275.0%
2008 21.0% +40.0%
2009 19.0% -9.5%
2010 20.0% +5.3%
2011 26.0% +30.0%
2012 34.0% +30.8%
2013 43.0% +26.5%
2014 44.0% +2.3%
2015 53.0% +20.5%
2016 66.0% +24.5%
2017 61.0% -7.6%
2018 65.0% +6.6%
2019 68.0% +4.6%
2020 83.0% +22.1%
2021 65.0% -21.7%
2022 70.0% +7.7%
2023 63.0% -10.0%
2024 72.0% +14.3%

Gabon compared with similar countries

  • Gabon's 72.0% is below the median for upper middle income countries, which is 79.5%, 91% of the median. (22 countries reporting)
  • Gabon's 72.0% is below the median for Sub-Saharan Africa, which is 82.0%, 88% of the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Gabon changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2007 +275.0% 4.0% 15.0%
2004 +200.0% 1.0% 3.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.6% 0.0% 21.0% 10
2010s 48.0% 20.0% 68.0% 10
2020s 70.6% 63.0% 83.0% 5

Countries ranked near Gabon

  1. 46 Chad 77.0% compare
  2. 46 Gambia 77.0% compare
  3. 48 Algeria 74.0% compare
  4. 49 Morocco 72.0% compare
  5. 51 Libya 70.0% compare
  6. 52 Burkina Faso 69.0% compare
  7. 52 Central African Republic 69.0% compare

See the full ranking of 99 places →

More health data for Gabon

All data for Gabon →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Gabon?
Antiretroviral therapy coverage for pmtct in Gabon was 72.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Gabon?
The highest recorded value was 83.0% in 2020.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Gabon?
The lowest recorded value was 0.0% in 2000.
How does Gabon rank for antiretroviral therapy coverage for pmtct?
Gabon ranks 49th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Gabon?
Over the last ten years it is up 63.6%. The long-run trend across the full record is volatile.
Where does this Gabon data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Gabon. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/gabon/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/gabon/">Antiretroviral therapy coverage for PMTCT in Gabon</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).